‹
›
This content requires a premium subscription.
Please
log in
or
subscribe
to continue.
JAMA Oncology Author Interviews
Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Breast Cancer Screening
30
00:00:00
/ 00:12:11
30